 | • レポートコード：B-GIR08C4020 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ニボルマブの世界市場について調べ、まとめました。種類別セグメントは、注射剤4mL、注射剤10mL等、用途別セグメントは、切除不能黒色腫、転移性黒色腫、転移性扁平上皮癌、古典的ホジキンリンパ腫、腎細胞癌、その他等に区分しました。ニボルマブの世界市場概観、企業動向、企業別ニボルマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ニボルマブの市場概観 ・ニボルマブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ニボルマブの企業別販売動向、市場シェア、市場集中度、競争動向 ・ニボルマブの世界市場規模 ・ニボルマブの北米市場分析（アメリカ、カナダ、メキシコ等） ・ニボルマブのアメリカ市場規模推移 ・ニボルマブのカナダ市場規模推移 ・ニボルマブのメキシコ市場規模推移 ・ニボルマブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ニボルマブのドイツ市場規模推移 ・ニボルマブのイギリス市場規模推移 ・ニボルマブのロシア市場規模推移 ・ニボルマブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ニボルマブの日本市場規模推移 ・ニボルマブの中国市場規模推移 ・ニボルマブの韓国市場規模推移 ・ニボルマブのインド市場規模推移 ・ニボルマブの東南アジア市場規模推移 ・ニボルマブの南米市場分析（ブラジル、アルゼンチン等） ・ニボルマブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ニボルマブの種類別分析/販売量、売上、市場シェア（注射剤4mL、注射剤10mL） ・ニボルマブの用途別分析/市場規模（切除不能黒色腫、転移性黒色腫、転移性扁平上皮癌、古典的ホジキンリンパ腫、腎細胞癌、その他） ・ニボルマブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ニボルマブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Nivolumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Nivolumab in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Ono Pharmaceutical
Bristol-Myers Squibb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Injection 4mL
Injection 10mL
Market Segment by Applications, can be divided into
Unresectable Melanoma
Metastatic Melanoma
Metastatic Squamous NSCLC
Classical Hodgkin Lymphoma
Renal Cell Carcinoma
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nivolumab product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nivolumab, with price, sales, revenue and global market share of Nivolumab in 2017 and 2018.
Chapter 3, the Nivolumab competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nivolumab breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Nivolumab market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Nivolumab sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Nivolumab Introduction
1.2 Market Analysis by Type
1.2.1 Injection 4mL
1.2.2 Injection 10mL
1.3 Market Analysis by Applications
1.3.1 Unresectable Melanoma
1.3.2 Metastatic Melanoma
1.3.3 Metastatic Squamous NSCLC
1.3.4 Classical Hodgkin Lymphoma
1.3.5 Renal Cell Carcinoma
1.3.6 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Ono Pharmaceutical
2.1.1 Business Overview
2.1.2 Nivolumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Ono Pharmaceutical Nivolumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bristol-Myers Squibb
2.2.1 Business Overview
2.2.2 Nivolumab Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bristol-Myers Squibb Nivolumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Nivolumab Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Nivolumab Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Nivolumab Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Nivolumab Manufacturer Market Share in 2018
3.3.2 Top 6 Nivolumab Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Nivolumab Market Analysis by Regions
4.1 Global Nivolumab Sales, Revenue and Market Share by Regions
4.1.1 Global Nivolumab Sales and Market Share by Regions (2014-2019)
4.1.2 Global Nivolumab Revenue and Market Share by Regions (2014-2019)
4.2 North America Nivolumab Sales and Growth Rate (2014-2019)
4.3 Europe Nivolumab Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Nivolumab Sales and Growth Rate (2014-2019)
4.5 South America Nivolumab Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Nivolumab Sales and Growth Rate (2014-2019)
5 North America Nivolumab by Country
5.1 North America Nivolumab Sales, Revenue and Market Share by Country
5.1.1 North America Nivolumab Sales and Market Share by Country (2014-2019)
5.1.2 North America Nivolumab Revenue and Market Share by Country (2014-2019)
5.2 United States Nivolumab Sales and Growth Rate (2014-2019)
5.3 Canada Nivolumab Sales and Growth Rate (2014-2019)
5.4 Mexico Nivolumab Sales and Growth Rate (2014-2019)
6 Europe Nivolumab by Country
6.1 Europe Nivolumab Sales, Revenue and Market Share by Country
6.1.1 Europe Nivolumab Sales and Market Share by Country (2014-2019)
6.1.2 Europe Nivolumab Revenue and Market Share by Country (2014-2019)
6.2 Germany Nivolumab Sales and Growth Rate (2014-2019)
6.3 UK Nivolumab Sales and Growth Rate (2014-2019)
6.4 France Nivolumab Sales and Growth Rate (2014-2019)
6.5 Russia Nivolumab Sales and Growth Rate (2014-2019)
6.6 Italy Nivolumab Sales and Growth Rate (2014-2019)
7 Asia-Pacific Nivolumab by Country
7.1 Asia-Pacific Nivolumab Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Nivolumab Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Nivolumab Revenue and Market Share by Country (2014-2019)
7.2 China Nivolumab Sales and Growth Rate (2014-2019)
7.3 Japan Nivolumab Sales and Growth Rate (2014-2019)
7.4 Korea Nivolumab Sales and Growth Rate (2014-2019)
7.5 India Nivolumab Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Nivolumab Sales and Growth Rate (2014-2019)
8 South America Nivolumab by Country
8.1 South America Nivolumab Sales, Revenue and Market Share by Country
8.1.1 South America Nivolumab Sales and Market Share by Country (2014-2019)
8.1.2 South America Nivolumab Revenue and Market Share by Country (2014-2019)
8.2 Brazil Nivolumab Sales and Growth Rate (2014-2019)
8.3 Argentina Nivolumab Sales and Growth Rate (2014-2019)
8.4 Colombia Nivolumab Sales and Growth Rate (2014-2019)
9 Middle East and Africa Nivolumab by Countries
9.1 Middle East and Africa Nivolumab Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Nivolumab Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Nivolumab Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Nivolumab Sales and Growth Rate (2014-2019)
9.3 Turkey Nivolumab Sales and Growth Rate (2014-2019)
9.4 Egypt Nivolumab Sales and Growth Rate (2014-2019)
9.5 Nigeria Nivolumab Sales and Growth Rate (2014-2019)
9.6 South Africa Nivolumab Sales and Growth Rate (2014-2019)
10 Global Nivolumab Market Segment by Type
10.1 Global Nivolumab Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Nivolumab Sales and Market Share by Type (2014-2019)
10.1.2 Global Nivolumab Revenue and Market Share by Type (2014-2019)
10.2 Injection 4mL Sales Growth and Price
10.2.1 Global Injection 4mL Sales Growth (2014-2019)
10.2.2 Global Injection 4mL Price (2014-2019)
10.3 Injection 10mL Sales Growth and Price
10.3.1 Global Injection 10mL Sales Growth (2014-2019)
10.3.2 Global Injection 10mL Price (2014-2019)
11 Global Nivolumab Market Segment by Application
11.1 Global Nivolumab Sales Market Share by Application (2014-2019)
11.2 Unresectable Melanoma Sales Growth (2014-2019)
11.3 Metastatic Melanoma Sales Growth (2014-2019)
11.4 Metastatic Squamous NSCLC Sales Growth (2014-2019)
11.5 Classical Hodgkin Lymphoma Sales Growth (2014-2019)
11.6 Renal Cell Carcinoma Sales Growth (2014-2019)
11.7 Other Sales Growth (2014-2019)
12 Nivolumab Market Forecast (2019-2024)
12.1 Global Nivolumab Sales, Revenue and Growth Rate (2019-2024)
12.2 Nivolumab Market Forecast by Regions (2019-2024)
12.2.1 North America Nivolumab Market Forecast (2019-2024)
12.2.2 Europe Nivolumab Market Forecast (2019-2024)
12.2.3 Asia-Pacific Nivolumab Market Forecast (2019-2024)
12.2.4 South America Nivolumab Market Forecast (2019-2024)
12.2.5 Middle East and Africa Nivolumab Market Forecast (2019-2024)
12.3 Nivolumab Market Forecast by Type (2019-2024)
12.3.1 Global Nivolumab Sales Forecast by Type (2019-2024)
12.3.2 Global Nivolumab Market Share Forecast by Type (2019-2024)
12.4 Nivolumab Market Forecast by Application (2019-2024)
12.4.1 Global Nivolumab Sales Forecast by Application (2019-2024)
12.4.2 Global Nivolumab Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Nivolumab Picture
Table Product Specifications of Nivolumab
Figure Global Sales Market Share of Nivolumab by Types in 2018
Table Nivolumab Types for Major Manufacturers
Figure Injection 4mL Picture
Figure Injection 10mL Picture
Figure Nivolumab Sales Market Share by Applications in 2018
Figure Unresectable Melanoma Picture
Figure Metastatic Melanoma Picture
Figure Metastatic Squamous NSCLC Picture
Figure Classical Hodgkin Lymphoma Picture
Figure Renal Cell Carcinoma Picture
Figure Other Picture
Figure United States Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure France Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure UK Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure China Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure India Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Nivolumab Revenue (Value) and Growth Rate (2014-2024)
Table Ono Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Ono Pharmaceutical Nivolumab Type and Applications
Table Ono Pharmaceutical Nivolumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Nivolumab Type and Applications
Table Bristol-Myers Squibb Nivolumab Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Nivolumab Sales by Manufacturer (2017-2018)
Figure Global Nivolumab Sales Market Share by Manufacturer in 2017
Figure Global Nivolumab Sales Market Share by Manufacturer in 2018
Table Global Nivolumab Revenue by Manufacturer (2017-2018)
Figure Global Nivolumab Revenue Market Share by Manufacturer in 2017
Figure Global Nivolumab Revenue Market Share by Manufacturer in 2018
Figure Top 3 Nivolumab Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Nivolumab Manufacturer (Revenue) Market Share in 2018
Figure Global Nivolumab Sales and Growth Rate (2014-2019)
Figure Global Nivolumab Revenue and Growth Rate (2014-2019)
Table Global Nivolumab Sales by Regions (2014-2019)
Table Global Nivolumab Sales Market Share by Regions (2014-2019)
Table Global Nivolumab Revenue by Regions (2014-2019)
Figure Global Nivolumab Revenue Market Share by Regions (2014-2019)
Figure Global Nivolumab Revenue Market Share by Regions in 2018
Figure North America Nivolumab Sales and Growth Rate (2014-2019)
Figure Europe Nivolumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Nivolumab Sales and Growth Rate (2014-2019)
Figure South America Nivolumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Nivolumab Sales and Growth Rate (2014-2019)
Figure North America Nivolumab Revenue and Growth Rate (2014-2019)
Table North America Nivolumab Sales by Countries (2014-2019)
Table North America Nivolumab Sales Market Share by Countries (2014-2019)
Figure North America Nivolumab Sales Market Share by Countries (2014-2019)
Figure North America Nivolumab Sales Market Share by Countries in 2018
Table North America Nivolumab Revenue by Countries (2014-2019)
Table North America Nivolumab Revenue Market Share by Countries (2014-2019)
Figure North America Nivolumab Revenue Market Share by Countries (2014-2019)
Figure North America Nivolumab Revenue Market Share by Countries in 2018
Figure United States Nivolumab Sales and Growth Rate (2014-2019)
Figure Canada Nivolumab Sales and Growth Rate (2014-2019)
Figure Mexico Nivolumab Sales and Growth Rate (2014-2019)
Figure Europe Nivolumab Revenue and Growth Rate (2014-2019)
Table Europe Nivolumab Sales by Countries (2014-2019)
Table Europe Nivolumab Sales Market Share by Countries (2014-2019)
Table Europe Nivolumab Revenue by Countries (2014-2019)
Figure Europe Nivolumab Revenue Market Share by Countries (2014-2019)
Figure Europe Nivolumab Revenue Market Share by Countries in 2018
Figure Germany Nivolumab Sales and Growth Rate (2014-2019)
Figure UK Nivolumab Sales and Growth Rate (2014-2019)
Figure France Nivolumab Sales and Growth Rate (2014-2019)
Figure Russia Nivolumab Sales and Growth Rate (2014-2019)
Figure Italy Nivolumab Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Nivolumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Nivolumab Sales by Countries (2014-2019)
Table Asia-Pacific Nivolumab Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Nivolumab Sales Market Share by Countries 2018
Table Asia-Pacific Nivolumab Revenue by Countries (2014-2019)
Figure Asia-Pacific Nivolumab Revenue Market Share by Countries 2018
Figure China Nivolumab Sales and Growth Rate (2014-2019)
Figure Japan Nivolumab Sales and Growth Rate (2014-2019)
Figure Korea Nivolumab Sales and Growth Rate (2014-2019)
Figure India Nivolumab Sales and Growth Rate (2014-2019)
Figure Southeast Asia Nivolumab Sales and Growth Rate (2014-2019)
Figure South America Nivolumab Revenue and Growth Rate (2014-2019)
Table South America Nivolumab Sales by Countries (2014-2019)
Table South America Nivolumab Sales Market Share by Countries (2014-2019)
Figure South America Nivolumab Sales Market Share by Countries in 2018
Table South America Nivolumab Revenue by Countries (2014-2019)
Table South America Nivolumab Revenue Market Share by Countries (2014-2019)
Figure South America Nivolumab Revenue Market Share by Countries in 2018
Figure Brazil Nivolumab Sales and Growth Rate (2014-2019)
Figure Argentina Nivolumab Sales and Growth Rate (2014-2019)
Figure Colombia Nivolumab Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Nivolumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Nivolumab Sales by Countries (2014-2019)
Table Middle East and Africa Nivolumab Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Nivolumab Sales Market Share by Countries in 2018
Table Middle East and Africa Nivolumab Revenue by Countries (2014-2019)
Table Middle East and Africa Nivolumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nivolumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Nivolumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Nivolumab Sales and Growth Rate (2014-2019)
Figure UAE Nivolumab Sales and Growth Rate (2014-2019)
Figure Egypt Nivolumab Sales and Growth Rate (2014-2019)
Figure Nigeria Nivolumab Sales and Growth Rate (2014-2019)
Figure South Africa Nivolumab Sales and Growth Rate (2014-2019)
Table Global Nivolumab Sales by Type (2014-2019)
Table Global Nivolumab Sales Share by Type (2014-2019)
Table Global Nivolumab Revenue by Type (2014-2019)
Table Global Nivolumab Revenue Share by Type (2014-2019)
Figure Global Injection 4mL Sales Growth (2014-2019)
Figure Global Injection 4mL Price (2014-2019)
Figure Global Injection 10mL Sales Growth (2014-2019)
Figure Global Injection 10mL Price (2014-2019)
Table Global Nivolumab Sales by Application (2014-2019)
Table Global Nivolumab Sales Share by Application (2014-2019)
Figure Global Metastatic Melanoma Sales Growth (2014-2019)
Figure Global Metastatic Squamous NSCLC Sales Growth (2014-2019)
Figure Global Classical Hodgkin Lymphoma Sales Growth (2014-2019)
Figure Global Renal Cell Carcinoma Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Nivolumab Sales, Revenue and Growth Rate (2019-2024)
Table Global Nivolumab Sales Forecast by Regions (2019-2024)
Table Global Nivolumab Market Share Forecast by Regions (2019-2024)
Figure North America Sales Nivolumab Market Forecast (2019-2024)
Figure Europe Sales Nivolumab Market Forecast (2019-2024)
Figure Asia-Pacific Sales Nivolumab Market Forecast (2019-2024)
Figure South America Sales Nivolumab Market Forecast (2019-2024)
Figure Middle East and Africa Sales Nivolumab Market Forecast (2019-2024)
Table Global Nivolumab Sales Forecast by Type (2019-2024)
Table Global Nivolumab Market Share Forecast by Type (2019-2024)
Table Global Nivolumab Sales Forecast by Application (2019-2024)
Table Global Nivolumab Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の転移性ぶどう膜黒色腫市場2019 The global Metastatic Uveal Melanoma Thereapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Metastatic Uveal Melanoma Thereapeutics market status and forecast, categorizes the global …- PD-1阻害剤の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Scope of the Report: The global PD-1 Inhibitor market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast …
- ペンブロリズマブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Pembrolizumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Pembrolizumab in global m…
- デュルバルマブの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Durvalumab is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Durvalumab in global market,…
- 腎細胞癌治療薬市場：世界及び中国市場分析・予測（～2024年） Renal Cell Carcinoma Drugs Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Renal Cell Carcinoma Drugs industry with a focus on the Chinese market. The report provides key statistics on the market status of the Renal Cell Carci…